Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)
28.42
+0.22 (0.78%)
Nov 6, 2026, 9:25 AM CST
Assure Tech (Hangzhou) Revenue
Assure Tech (Hangzhou) had revenue of 104.10M CNY in the quarter ending September 30, 2026, with 8.96% growth. This brings the company's total for the last twelve months to 418.93M, down -9.46% year-over-year. In the year 2025, Assure Tech (Hangzhou) had annual revenue of 451.26M, down -16.54%. That makes Assure Tech (Hangzhou) the 26,233rd largest company in the world by revenue and 4,616th in China.
Revenue (ttm)
418.93M
Revenue Growth
-9.46%
P/S Ratio
8.58
Revenue / Employee
731.11K
Employees
573
Market Cap
3.59B
Revenue by Geography
- Overseas 429.00M 95.1%
- China 22.25M 4.9%
Fiscal year ended Dec 31, 2025 See the full Assure Tech (Hangzhou) breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 451.26M | -89.44M | -16.54% |
| Dec 31, 2024 | 540.70M | 37.34M | 7.42% |
| Dec 31, 2023 | 503.36M | -5.66B | -91.84% |
| Dec 31, 2022 | 6.17B | 4.58B | 287.97% |
| Dec 31, 2021 | 1.59B | 389.51M | 32.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.88B |
| Wuhan Hvsen Biotechnology | 1.71B |
| Hefei Lifeon Pharmaceutical | 1.46B |
| Beijing Konruns Pharmaceutical | 863.12M |
| Beijing Bohui Innovation Biotechnology Group | 821.94M |
| Shanghai Model Organisms Center | 486.90M |
| Beijing Scitop Bio-tech | 365.18M |
| Jiangsu Sihuan Bioengineering | 283.86M |